SUVmax shows survival for NSCLC patients

February 11, 2013

Maximum standardized uptake value (SUVmax) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to a study presented at the Cancer Imaging and Radiation Therapy Symposium.